Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity?
To date, hypolipidemic drugs of the statin group are among the most popular therapeutic agents used for the prevention and treatment of the most common worldwide atherosclerotic cardiovascular diseases (CVD). Therefore, considerable attention of researchers is focused on statins to study the additio...
| Published in: | Рациональная фармакотерапия в кардиологии |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2023-05-01
|
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2764 |